Headlines

Chris Lewis

Chris Lewis is Tech Insider's Senior Equity Research analyst covering Internet and Interactive Entertainment. Prior to joining TI in 2011, Chris spent six years at Baird Capital having established the company’s Internet and Video Game research practice. Prior to Wall Street, Chris was a business analyst developing software at Chubb Corporation, and was a co-founder and CFO of Latin American career services website Detacuche.com. Chris appears frequently in the financial and industry press, including CNBC, Bloomberg, CNN, Wall Street Journal, and Financial Times, among others.

Asset Management: Bank of New York Mellon (NYSE:BK), Blackstone Group (NYSE:BX), KKR & Co. (NYSE:KKR), Franklin Resources (NYSE:BEN)

Chris Lewis02 mins

The Bank of New York Mellon, Corporation (NYSE:BK) land with building(s), 20 E. Washington St., Nelsonville, to Michael Mark, $28,000.The Bank of New York Mellon Corporation (NYSE:BK) stock performance was -0.12% in last session and finished the day at $33.13. Traded volume was 10,727,284 million shares in the last session and the average volume of…

Read More

Biotech Top Gainer: Ariad Pharmaceuticals (NASDAQ:ARIA), CEL-SCI Corporation (NYSEMKT:CVM), Synthetic Biologics (NYSEMKT:SYN), Agenus Inc. (NASDAQ:AGEN)

Chris Lewis02 mins

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) on Feb. 25 reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was 8.79% in last session and finished the day at $8.17. Traded volume was 18.32 million shares in the last session…

Read More
FB Nasdaq FB Facebook

Diversified Electronics Losers: Plug Power Inc (NASDAQ:PLUG), Hutchinson Technology Incorporated (NASDAQ:HTCH), Deutsche Post (FRA:DPW), Microvision (NASDAQ:MVIS)

Chris Lewis02 mins

MTI Micro did get close to commercializing its Mobion fuel cell, which is powered by methanol. It was originally designed to charge and power cellphones and other personal electronic devices. But the device never had the success of Plug Power Inc (NASDAQ:PLUG), a local fuel cell company that has focused on the forklift truck market….

Read More

Drug manufacturer Most Active: Merck & Co. (NYSE:MRK), Bristol-Myers Squibb (NYSE:BMY), Johnson & Johnson (NYSE:JNJ), Raptor Pharmaceutical (NASDAQ:RPTP)

Chris Lewis02 mins

Bristol-Myers Squibb Co (NYSE:BMY)’s ipilimumab, or Yervoy as it’s commercially known, was dubbed the skin cancer ‘wonder’ drug by the media when it was licensed for use in the UK in 2011. Bristol-Myers Squibb Co (NYSE:BMY) dropped -0.33 percent to $54.00 Friday on volume of 8.05million shares. The intra-day range of the stock was $53.88…

Read More

Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Chris Lewis02 mins

CytRx Corporation (NASDAQ:CYTR) reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -12.76% in last session and finished the day at $4.17. Traded volume was 11,065,087 million shares in the last…

Read More

Biotech Top Losers: Geron Corporation (NASDAQ:GERN), Synta Pharmaceuticals (NASDAQ:SNTA), Northwest Biotherapeutics (NASDAQ:NWBO), AEterna Zentaris (NASDAQ:AEZS)

Chris Lewis02 mins

Geron Corporation (NASDAQ:GERN) said the US Food and Drug Administration ordered a halt to trials of a cancer drug over concerns about potential liver damage. Geron Corporation (NASDAQ:GERN) stock performance was -61.59% in last session and finished the day at $1.69. Traded volume was 46,444,384 million shares in the last session and the average volume…

Read More
Home